Biocon gets USFDA nod for generic product

Biotechnology major Biocon on Thursday said its unit has received approval from the US health regulator to market a generic product.

Biocon Pharma, a subsidiary of the company, has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Mycophenolic Acid, the company said in a regulatory filing.

The product is indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant and is available in 180mg and 360mg strengths.

This approval further adds to Biocon’s portfolio of vertically integrated complex drug products, the company noted.

  • Related Posts

    Hyderabad pharma firm executives donate ₹2 crore to TTD scheme in Tirumala

    Biophore India Pharmaceuticals chief executive officer Jagadish and chief strategy officer Manik Reddy Pullagurla each contributed ₹1 crore; TTD chairman B.R. Naidu received the demand drafts at his Tirumala Camp…

    Pharma pricing policy threatens innovation

    Limited price adjustments have squeezed profitability, say manufacturers Bangladesh: Bangladesh’s pharmaceutical industry is urging the government to review the country’s medicine pricing policy, saying years of limited price adjustments have…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Hyderabad pharma firm executives donate ₹2 crore to TTD scheme in Tirumala

    Hyderabad pharma firm executives donate ₹2 crore to TTD scheme in Tirumala

    Pharma pricing policy threatens innovation

    Pharma pricing policy threatens innovation

    16 empanelled hospitals face action after negligence in Ayushman Scheme

    16 empanelled hospitals face action after negligence in Ayushman Scheme

    Hollywood fame Bollywood Babe Neetu Chandra emerges a Cancer Crusader worldwide

    Hollywood fame Bollywood Babe Neetu Chandra emerges a Cancer Crusader worldwide

    18 maternal deaths still a ‘mystery’, says Rajasthan health minister

    18 maternal deaths still a ‘mystery’, says Rajasthan health minister

    FDA suspends licence of Pune’s Metro Blood Bank; 10 district blood centres face action

    FDA suspends licence of Pune’s Metro Blood Bank; 10 district blood centres face action